用力肺活量低于1:高危患者的标志
该回顾性研究纳入2009至2014年某一级创伤中心肋骨骨折照护路径中入院用力肺活量大于1的1106例患者,比较住院期间最低用力肺活量低于1(A组,187例)与不低于1(B组,919例)的并发症情况。A组总并发症率15% vs B组3.2%(p<0.001),肺炎9% vs 1.4%、再入院4% vs 1.7%、非计划升级至ICU 3.7% vs 0.2%、插管1.6% vs 0.1%均显著更高,住院时间10天 vs 4天(p<0.001)。作者认为用力肺活量可预测肋骨骨折患者并发症,住院期间每日检测用力肺活量有助于判断预后,一旦降至1以下应考虑加强干预和更高等级照护。
要点
- 肋骨骨折患者住院期间最低用力肺活量低于1者总并发症率15%,显著高于用力肺活量不低于1者的3.2%(p<0.001)。
- 用力肺活量低于1组肺炎9% vs 1.4%、非计划升级至ICU 3.7% vs 0.2%、插管1.6% vs 0.1%,均显著更高。
- 用力肺活量低于1组再入院4% vs 1.7%(p=0.04),住院时间10天 vs 4天(p<0.001)。
- 作者认为每日用力肺活量检测可预测肋骨骨折患者结局,用力肺活量低于1应视为并发症标志。
- 作者建议一旦用力肺活量降至1以下,即使临床尚未恶化,也应考虑加强干预和更高等级照护。
适用人群与场景
- 某一级创伤中心2009至2014年纳入肋骨骨折照护路径的患者,入院用力肺活量大于1。
- 排除无入院用力肺活量记录的患者。
诊断标准与关键阈值
- 以住院期间最低用力肺活量低于1为高危阈值,与最低用力肺活量不低于1者比较。
处置流程与药物剂量
- 作者认为对肋骨骨折住院患者应每日检测用力肺活量以预测结局。
- 作者建议一旦用力肺活量降至1以下,即使患者临床尚未恶化,也应考虑加强干预和更高等级照护。
红旗征与不能漏的情况
- 住院期间用力肺活量降至1以下提示肺炎、非计划升级至ICU、再入院和插管风险显著升高。
研究设计与关键结果
- 回顾性研究,共分析1106例肋骨骨折患者,A组(最低用力肺活量低于1)187例,B组(最低用力肺活量不低于1)919例。
- 总并发症率A组15% vs B组3.2%(p<0.001)。
- 肺炎A组9% vs B组1.4%(p<0.001);再入院A组4% vs B组1.7%(p=0.04);非计划升级至ICU A组3.7% vs B组0.2%(p<0.001);插管A组1.6% vs B组0.1%(p=0.02)。
- 住院时间A组10天 vs B组4天(p<0.001)。
证据类型、等级与局限
- 预后研究,证据等级III级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为用力肺活量可预测肋骨骨折患者并发症,每日用力肺活量检测有助于判断预后。
- 作者建议用力肺活量低于1应作为并发症标志,一旦降至1以下应考虑加强干预和更高等级照护,即使临床尚未恶化。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Rib fractures (RFx) continue to be a source of morbidity and mortality. A RFx care pathway has been used based on forced vital capacity (FVC). The objective of this study was to test the hypothesis that deterioration of FVC to less than 1 after admission is a marker for high-risk patients and affects outcomes.
METHODS: A retrospective study of patients enrolled in an RFx care pathway at a Level 1 trauma center from 2009 to 2014. All patients had an admission FVC greater than 1. 2 groups were analyzed: patients with a lowest inpatient FVC less than 1 (Group A) compared to patients with lowest inpatient FVC of 1 or greater (Group B). Complications [pneumonia, upgrade to the intensive care unit, readmission, and intubation] and demographics were examined. Patients without documented admission FVCs were excluded. p < 0.05 was considered significant.
RESULTS: A total of 1,106 patients were analyzed (Group A, 187; Group B, 919). Patients whose FVC dropped less than 1 (Group A) had a higher complication rate [15% (Group A) vs 3.2% (Group B); p < 0.001]. Rates of pneumonia, readmission, unplanned upgrade, and intubation were all significantly higher in Group A [pneumonia: 9% (Group A) vs 1.4% (Group B), p < 0.001; readmission: 4% (Group A) vs 1.7% (Group B), p = 0.04; upgrade; 3.7% (Group A) vs 0.2% (Group B), p < 0.001; intubation: 1.6% (Group A) vs 0.1% (Group B), p = 0.02]. Hospital length of stay was longer in Group A [10 days (Group A) vs 4 days (Group B), p < 0.001].
CONCLUSIONS: Forced vital capacity predicts complications in patients with RFx. Patients whose FVC falls less than 1 during admission are at high risk for pulmonary complications. Daily FVC testing for patients admitted with RFx can predict outcomes. Forced vital capacity less than 1 should be considered as a marker for complications. Once FVC drops less than 1, patients should be considered for increased interventions. Even if the patient has not yet clinically deteriorated, consideration for higher level of care is warranted.
LEVEL OF EVIDENCE: Prognostic study, level III.
参考来源
- Warner R, Knollinger P, Hobbs G, et al. Forced vital capacity less than 1: A mark for high-risk patients. J Trauma Acute Care Surg. 2018. PMID: 30080778. doi:10.1097/TA.0000000000001954
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。